This topic contains a solution. Click here to go to the answer

Author Question: The hypothesis states that intelligent people show weaker neural activations in a smaller number of ... (Read 65 times)

KimWrice

  • Hero Member
  • *****
  • Posts: 579
The hypothesis states that intelligent people show weaker neural activations in a smaller number of areas than less intelligent people.
 
  a. biological
  b. neurophysiological
  c. neural efficiency
  d. neural activation

Question 2

Which of the following is not a social demographic variable implicated in reducing rates of intellectual decline?
 
  a. having a complex job
  b. exposure to stimulating environments
  c. utilization of cultural and educational resources
  d. low educational level



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Kedrick2014

  • Sr. Member
  • ****
  • Posts: 359
Answer to Question 1

ANSWER: c

Answer to Question 2

ANSWER: d





 

Did you know?

When Gabriel Fahrenheit invented the first mercury thermometer, he called "zero degrees" the lowest temperature he was able to attain with a mixture of ice and salt. For the upper point of his scale, he used 96°, which he measured as normal human body temperature (we know it to be 98.6° today because of more accurate thermometers).

Did you know?

Approximately 500,000 babies are born each year in the United States to teenage mothers.

Did you know?

Nearly all drugs pass into human breast milk. How often a drug is taken influences the amount of drug that will pass into the milk. Medications taken 30 to 60 minutes before breastfeeding are likely to be at peak blood levels when the baby is nursing.

Did you know?

The most destructive flu epidemic of all times in recorded history occurred in 1918, with approximately 20 million deaths worldwide.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library